ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2025
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome.
Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
BACKGROUND &
aimsLittle is known about ambulatory acute kidney injury (A-AKI), which develops in an outpatient setting.
methodsWe conducted a retrospective cohort study of patients diagnosed with cirrhosis between January 1, 2018, and December 31, 2019 from 130 hospitals in the Veterans Affairs healthcare system. Patients were classified as having incident A-AKI if they met the International Club of Ascites AKI criteria in an outpatient setting. We used multivariable regression models to identify factors associated with A-AKI development within 1 year of cirrhosis diagnosis. We also conducted a structured implicit review of patients' medical charts to determine the precipitants of A-AKI. We examined the rates of AKI-resolution, hemodialysis and death at 90 days.
resultsAmong 55,880 patients with cirrhosis [median age 66 years, 38% alcohol-related cirrhosis (alcohol-associated liver disease), median Model for End-Stage Liver Disease-Sodium 10, 34% ascites] followed for a median of 3.4 years, 6889 (12%) patients developed incident A-AKI. Patients with ascites (odds ratio [OR], 2.51), Model for End-Stage Liver Disease-Sodium >15 (OR, 1.58), hepatocellular carcinoma (OR, 1.45) or alcohol-associated liver disease (OR, 1.37) had higher odds of developing A-AKI. In total, 60% had AKI-resolution, 4.5% progressed to hemodialysis, and 12% died within 90 days of A-AKI onset. In a review of medical records of 250 randomly selected patients with A-AKI, key precipitants were hypovolemia due to diuretics and gastrointestinal losses, and nephrotoxin medication exposure. Overall, 42% of A-AKI events were unrecognized.
conclusionsA-AKI is common in cirrhosis, associated with high 90-day mortality, and significantly under-recognized. Targeted interventions for early diagnosis and treatment could improve outcomes in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.